Frasier syndrome presenting with persistent Pseudomonas aeruginosa bacteremia during intensive immunosuppressive therapy: a case report.

IF 1 Q4 UROLOGY & NEPHROLOGY
Mizuki Odagi, Tomohiko Yamamura, Yuka Kimura, Shuhei Aoyama, Yuta Inoki, Hideaki Kitakado, Chika Ueda, Yu Tanaka, Tomoko Horinouchi, China Nagano, Shingo Ishimori, Norishige Yoshikawa, Kandai Nozu
{"title":"Frasier syndrome presenting with persistent Pseudomonas aeruginosa bacteremia during intensive immunosuppressive therapy: a case report.","authors":"Mizuki Odagi, Tomohiko Yamamura, Yuka Kimura, Shuhei Aoyama, Yuta Inoki, Hideaki Kitakado, Chika Ueda, Yu Tanaka, Tomoko Horinouchi, China Nagano, Shingo Ishimori, Norishige Yoshikawa, Kandai Nozu","doi":"10.1007/s13730-026-01209-z","DOIUrl":null,"url":null,"abstract":"<p><p>Childhood-onset steroid-resistant nephrotic syndrome (SRNS) is caused by monogenic abnormalities in approximately 30% of cases, and is generally unresponsive to immunosuppressive therapy. However, in routine clinical practice, additional immunosuppression is often initiated before the results of genetic testing become available, thereby potentially increasing the risk of severe infection. We report the case of a 3-year-old girl with SRNS in which kidney biopsy showed focal segmental glomerulosclerosis, and there was persistent heavy proteinuria despite methylprednisolone pulse therapy and oral cyclosporin. During the clinical course, she developed persistent Pseudomonas aeruginosa bacteremia, and contrast-enhanced computed tomography suggested portal vein thrombosis as the infectious focus. Genetic testing subsequently identified a WT1 variant (NM_024426.6: c.1447 + 4C > T), establishing the diagnosis of Frasier syndrome. After immunosuppressive therapy was discontinued, in conjunction with ongoing antimicrobial and supportive treatment, she became afebrile and blood cultures became negative. This case highlights not only the importance of early genetic testing in SRNS to avoid ineffective immunosuppressive therapy, but also the potential for intensive immunosuppression to precipitate life-threatening infection, even in pediatric patients.</p>","PeriodicalId":9697,"journal":{"name":"CEN Case Reports","volume":"15 6","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CEN Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13730-026-01209-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Childhood-onset steroid-resistant nephrotic syndrome (SRNS) is caused by monogenic abnormalities in approximately 30% of cases, and is generally unresponsive to immunosuppressive therapy. However, in routine clinical practice, additional immunosuppression is often initiated before the results of genetic testing become available, thereby potentially increasing the risk of severe infection. We report the case of a 3-year-old girl with SRNS in which kidney biopsy showed focal segmental glomerulosclerosis, and there was persistent heavy proteinuria despite methylprednisolone pulse therapy and oral cyclosporin. During the clinical course, she developed persistent Pseudomonas aeruginosa bacteremia, and contrast-enhanced computed tomography suggested portal vein thrombosis as the infectious focus. Genetic testing subsequently identified a WT1 variant (NM_024426.6: c.1447 + 4C > T), establishing the diagnosis of Frasier syndrome. After immunosuppressive therapy was discontinued, in conjunction with ongoing antimicrobial and supportive treatment, she became afebrile and blood cultures became negative. This case highlights not only the importance of early genetic testing in SRNS to avoid ineffective immunosuppressive therapy, but also the potential for intensive immunosuppression to precipitate life-threatening infection, even in pediatric patients.

弗雷泽综合征在强化免疫抑制治疗期间呈现持续性铜绿假单胞菌菌血症:1例报告。
儿童期发作的类固醇抵抗性肾病综合征(SRNS)在大约30%的病例中是由单基因异常引起的,并且通常对免疫抑制治疗无反应。然而,在常规临床实践中,在获得基因检测结果之前,通常会启动额外的免疫抑制,从而潜在地增加严重感染的风险。我们报告一例患有SRNS的3岁女孩,其肾活检显示局灶节段性肾小球硬化,尽管甲基强的松龙脉冲治疗和口服环孢素,但仍有持续的重度蛋白尿。在临床过程中,她出现了持续性的铜绿假单胞菌菌血症,增强计算机断层扫描显示门静脉血栓形成为感染病灶。随后,基因检测鉴定出WT1变异(NM_024426.6: c.1447 + 4C > T),确定了弗雷泽综合征的诊断。在停止免疫抑制治疗后,结合正在进行的抗菌素和支持治疗,她开始发热,血培养呈阴性。该病例不仅强调了SRNS早期基因检测的重要性,以避免无效的免疫抑制治疗,而且还强调了强化免疫抑制可能导致危及生命的感染,即使在儿科患者中也是如此。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CEN Case Reports
CEN Case Reports UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
80
期刊介绍: Clinical and Experimental Nephrology (CEN) Case Reports is a peer-reviewed online-only journal, officially published biannually by the Japanese Society of Nephrology (JSN).  The journal publishes original case reports in nephrology and related areas.  The purpose of CEN Case Reports is to provide clinicians and researchers with a forum in which to disseminate their personal experience to a wide readership and to review interesting cases encountered by colleagues all over the world, from whom contributions are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书